A key federal advisory committee is set to consider on Tuesday whether to recommend that a pediatric dose of the Pfizer-BioNTech coronavirus vaccine be offered to 5- to 11-year-olds, setting in motion a string of decisions that could lead to children ...
from Google Alert - health https://ift.tt/3nwelVO
via IFTTT
0 comments:
Post a Comment